Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.

1st Affiliated Hospital Sun Yat sen University International Airway Research Center Guangzhou China

Academic Medical Center University of Amsterdam Department of Otorhinolaryngology Amsterdam the Netherlands

Akershus University Hospital Department of Otorhinolaryngology and Head and Neck surgery Division of Surgery Norway

Allergy and Asthma Center Westend Outpatient and Clinical Research Center Berlin Germany

Charite Berlin Germany

David Hide Centre St Mary's Hospital Isle of Wight and University of Southampton Southampton United Kingdom

Department of Clinical Pharmacy and Pharmacology University of Groningen University Medical Center of Groningen and QPS NL Groningen the Netherlands

Department of Otorhinolaryngology Head and Neck Surgery University of Southern Denmark Odense Denmark

Department of Respiratory Medicine 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Respiratory Medicine and Allergology Institute for Clinical Science Skane University Hospital Lund University Lund Sweden

Department of Respiratory Medicine and Allergology Skane University Hospital Lund University Sweden

Dept of Otorhinolaryngology Düsseldorf University Hospital Germany

Division of ENT Diseases CLINTEC Karolinska Institute University of Stockholm Sweden

Food Allergy Referral Centre Veneto Region Department of Women and Child Health Padua General University Hospital Padua Italy

Royal National TNE Hospital and Department of Immunology University College London United Kingdom

University Hospitals Leuven Department of Otorhinolaryngology Head and Neck Surgery Leuven Belgium

Upper Airways Research Laboratory and Department of Oto Rhino Laryngology Ghent University Belgium

Wiesbaden Center for Rhinology and Allergology Wiesbaden Germany

See more in PubMed

Carol H., YanFaraji F., Prajapti D.P., Boone C.E., DeConde A.S. International Forum of Allergy & Rhinology; 2020. Association of Chemosensory Dysfunction and Covid-19 in Patients Presenting with Influenza-like Symptoms. PubMed PMC

CDC COVID-19 Response Team Coronavirus disease 2019 in children - United States, february 12-april 2, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422–426. PubMed PMC

He X., Lau E.H.Y., Wu P. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:672–675. doi: 10.1038/s41591-020-0869-5. PubMed DOI

Bousquet J., Akdis C., Jutel M. 2020. Intranasal Corticosteroids in Allergic Rhinitis in COVID-19 Infected Patients: An ARIA-EAACI Statement Allergy. PubMed DOI

Minshall E., Ghaffar O., Cameron L. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998 May;118(5):648–654. PubMed PMID: 9591864. PubMed

Holmberg K., Pipkorn U. Influence of topical beclomethasone dipropionate suspension on human nasal mucociliary activity. Eur J Clin Pharmacol. 1986;30:625. PubMed

Halpin D.M.G., Singh D., Hadfield R.M. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020 doi: 10.1183/13993003.01009-2020. in press. PubMed DOI PMC

Halpin D.M.G., Faner R., Sibila O., Badia J.R., Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438. doi: 10.1016/S2213-2600(20)30167-3. Published Online April 3, 2020. PubMed DOI PMC

https://ginasthma.org/covid-19-gina-answers-to-frequently-asked-questions-on-asthma-management/

https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fspecific-groups%2Fasthma.html accessed 15.4.20.

Zhang J.J., Dong X., Cao Y.Y. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print, 2020 Feb 19] Allergy. 2020 doi: 10.1111/all.14238. PubMed DOI

Zhang Y., Zhang L. Prevalence of allergic rhinitis in China allergy asthma. Immunol Res. 2014 March;6(2):105–113. PubMed PMC

Istituto Superiore di Sanità Characteristics of COVID-19 patients dying in Italy Report based on available data on March 20th 2020. https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20

Canonica W., Cox L., Pawankar R. Sublingual immunotherapy: world Allergy Organization position paper 2013 update. World Allergy Org J. 2014;7:6. http://www.waojournal.org/content/7/1/6 PubMed PMC

Roberts G., Pfaar O., Akdis C.A. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018 Apr;73(4):765–798. PubMed

https://www.ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Anti-inflammatoires-non-steroidiens-AINS-et-complications-infectieuses-graves-Point-d-Information

https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19